TS-152

· Taisho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TS-152, covering 2025-02-28 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis [Phase 3]